Amyloid-β and mitochondria in aging and Alzheimer's disease: Implications for synaptic damage and cognitive decline

P. Hemachandra Reddy, Maria Manczak, Peizhong Mao, Marcus J. Calkins, Arubala P. Reddy, Ulziibat Shirendeb

Research output: Contribution to journalReview article

153 Scopus citations

Abstract

This article reviews the role of amyloid-β (Aβ) and mitochondria in synaptic damage and cognitive decline found in patients with Alzheimer's disease (AD). Recent molecular, cellular, animal model, and postmortem brain studies have revealed that Aβ and mitochondrial abnormalities are key factors that cause synaptic damage and cognitive decline in AD. Aβ is reported to accumulate in subcellular compartments and to impair the normal function of neurons in AD patients. Further, recent studies using biochemical methods and electron microscopy have revealed that the accumulation of Aβ at nerve terminals affect synaptic activities, including the release of neurotransmitters and synaptic vesicles. Recent studies of the relationship between mitochondria and Aβ in AD patients suggest that in mitochondria, structural changes caused by Aβ result in increased mitochondrial fragmentation, decreased mitochondrial fusion, mitochondrial dysfunction, and synaptic damage. This paper discusses the latest research on Aβ, mitochondria, age-dependent factors of AD in the brain, and synaptic damage in AD. This paper also briefly discusses potential mitochondrial therapeutics in the treatment of patients with AD.

Original languageEnglish
Pages (from-to)S499-S512
JournalJournal of Alzheimer's Disease
Volume20
Issue numberSUPPL.2
DOIs
StatePublished - Jan 1 2010

    Fingerprint

Keywords

  • Amyloid-β
  • amyloid-β precursor protein
  • mitochondrial therapeutics
  • synaptic pathology

Cite this